Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL
By: William G. Wierda, MD, PhD
Learning from BTK Inhibitors & Moving Forward the Therapeutic Field in CLL
By: William G. Wierda, MD, PhD
Management of Patients After CAR-T Therapy: Adverse Reactions and Follow Up
By: Brigett Brandjes, PA-C, MMSc
Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy
By: Christian Rolfo, MD, PhD, MBA, Dr.h.c.
Novel Platforms to Assess the Cancer Continuom Using Liquid Biopsy
By: Christian Rolfo, MD, PhD, MBA, Dr.h.c.
Convergence of Liquid Biopsy and Precision Oncology in the Management of NSCLC
By: David Gandara, MD & Jonathan W. Riess, MD, MS
Convergence of Liquid Biopsy and Precision Oncology in the Management of NSCLC
By: David Gandara, MD & Jonathan W. Riess, MD, MS
